India to Kenya: Ritonavir Export Trade Route

The India to Kenya Ritonavir corridor is one of India's established pharmaceutical export routes, with 48 shipments documented worth a combined $11.9M USD. The route is dominated by EMCURE PHARMACEUTICALS LIMITED, which alone accounts for roughly 35% of all export value, reflecting the consolidated nature of India's ritonavir manufacturing sector.

Across 9 active suppliers, the average shipment value stands at $247.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with ritonavir's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 33.9%, placing it at rank #20 among India's top ritonavir export destinations globally.

On the import side, key buyers of Indian ritonavir in Kenya include KENYA MEDICAL SUPPLIES AUTHORITY, KENYA MEDICAL SUPPLIES AUTHORITY COMMERCIAL STREET INDUSTRIAL AREA, NATIONAL MEDICAL STORES and 15 others. KENYA MEDICAL SUPPLIES AUTHORITY is the single largest importer with 5 shipments valued at $2.8M USD.

India's ritonavir exports to Kenya are driven primarily by a handful of large-scale manufacturers. EMCURE PHARMACEUTICALS LIMITED with 10 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — EMCURE PHARMACEUTICALS LIMITED, HETERO LABS LIMITED, MYLAN LABORATORIES LIMITED — together account for 72% of total trade value on this route. The average shipment value of $247.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as darunavir ritonavir 400mg 50mg tablet 60s batch nos e245295 e245296 e250090 e250092 e250093 e250133 e250464 e250465 e250 and darunavir+ritonavir 400mg+50mg tablet 60s, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, KENYA MEDICAL SUPPLIES AUTHORITY is the largest importer with 5 shipments worth $2.8M USD — representing 24% of all ritonavir imports from India on this route. A total of 18 buyers are active on this corridor.